Cargando…

Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus

INTRODUCTION: Patients with systemic lupus erythematosus (SLE) have persistent platelet activation and an increased risk of thrombotic events, which cannot be accounted for by traditional cardiovascular risk factors. Factor (F)XII has a potentially important role in thrombus formation and is trigger...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bäck, Jennie, Lood, Christian, Bengtsson, Anders A, Ekdahl, Kristina Nilsson, Nilsson, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979000/ https://www.ncbi.nlm.nih.gov/pubmed/24299152 http://dx.doi.org/10.1186/ar4399

Ejemplares similares

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
por: Svenungsson, Elisabet, et al.
Publicado: (2020)

Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
por: Bengtsson, Anders A., et al.
Publicado: (2020)

Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus
por: Han, Bobby Kwanghoon, et al.
Publicado: (2020)

The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
por: Compagno, Michele, et al.
Publicado: (2016)

Risk factors for thrombotic events in Korean patients with systemic lupus erythematosus
por: Park, Dong-Jin, et al.
Publicado: (2021)

Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System on Platelets in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2014)

Neutrophils - a complex story in the pathogenesis of systemic lupus erythematosus
por: Lood, Christian, et al.
Publicado: (2014)

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2017)

Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2019)

Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus
por: Mustelin, Tomas, et al.
Publicado: (2019)

Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus
por: Nielsen, Christoffer T, et al.
Publicado: (2014)

Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2015)

Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus
por: Leffler, Jonatan, et al.
Publicado: (2013)

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren’s Syndrome and Systemic Sclerosis
por: Bengtsson, Anders A., et al.
Publicado: (2016)

Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012)

Thrombotic thrombocytopenic purpura as the first presentation in systemic lupus erythematosus
por: Bamidele, Opeyemi Folorunsho, et al.
Publicado: (2018)

Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus
por: Zervides, Kristoffer A., et al.
Publicado: (2022)

Complement Diagnostics: Concepts, Indications, and Practical Guidelines
por: Nilsson, Bo, et al.
Publicado: (2012)

Postpartum Pulmonary-Renal Syndrome with Thrombotic Microangiopathy in Systemic Lupus Erythematosus
por: Jha, Vijoy Kumar, et al.
Publicado: (2023)

Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Wirestam, Lina, et al.
Publicado: (2019)

Thrombotic Microangiopathy among Hospitalized Patients with Systemic Lupus Erythematosus in the United States
por: Pivovarova, Aleksandra I., et al.
Publicado: (2020)

Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
por: Barber, Megan R.W., et al.
Publicado: (2022)

Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus
por: Bengtsson, Anders A, et al.
Publicado: (2014)

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

Interpretation of Serological Complement Biomarkers in Disease
por: Ekdahl, Kristina N., et al.
Publicado: (2018)

Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study
por: Zervides, Kristoffer A., et al.
Publicado: (2022)

Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus
por: Lood, Christian, et al.
Publicado: (2011)

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
por: Martin, Myriam, et al.
Publicado: (2017)

Sex differences in clinical presentation of systemic lupus erythematosus
por: Ramírez Sepúlveda, Jorge I., et al.
Publicado: (2019)

Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
por: Langensee, L., et al.
Publicado: (2022)

Systemic Lupus Erythematosus Presenting as Thrombotic Thrombocytopenia Purpura: How Close Is Close Enough?
por: Perez, Cesar A., et al.
Publicado: (2011)

Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: Successful management of a rare presentation
por: George, Pratish, et al.
Publicado: (2008)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
por: Wright, Rachael D., et al.
Publicado: (2020)

Systemic Lupus Erythematosus Presenting With Thrombotic Thrombocytopenic Purpura at Onset: A Case Report
por: Takagi, Yoko, et al.
Publicado: (2022)

Two concomitant thrombotic microangiopathies in the background of systemic lupus erythematosus: A case report
por: AlGhobaishi, Abdullah, et al.
Publicado: (2022)

Successful Treatment with Bortezomib for Refractory Thrombotic Thrombocytopenic Purpura Associated with Systemic Lupus Erythematosus
por: Yan, Ruyu, et al.
Publicado: (2022)

Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis
por: Qin, Ling, et al.
Publicado: (2019)

Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus
por: Zhang, Qiong, et al.
Publicado: (2019)

Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies
por: Nilsson, Ulf R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f3qdfo9qm92837lrs5kk4jhj6p